Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?-Reference-Cited by-同舟云学术

Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?

Published:2017-11-28 Issue:11 Volume:12 Page:e0188450
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Abdel-Rahman Omar^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. globocan.iarc.fr. Last accessed on 27/11/2016

2. Prostate cancer;G Attard;Lancet,2016

3. Management of patients with advanced prostate cancer: recommendations of the St. Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015;S Gillessen;Ann Oncol,2015

4. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging;MB Amin;CA Cancer J Clin,2017

5. Rusthoven CG, Carlson JA, Waxweiler TV, Yeh N, Raben D, Flaig TW, et al., editors. The prognostic significance of Gleason scores in metastatic prostate cancer. Urologic Oncology: Seminars and Original Investigations; 2014: Elsevier.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer in Latin America and the Caribbean: mortality trends from 1997 to 2017 and predictions to 2030;Salud Pública de México;2024-04-29

2. Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program;Scientific Reports;2023-06-19

3. Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification Reform;Annals of Surgical Oncology;2023-03-04

4. Cancer-directed surgery brings survival benefits for patients with advanced prostate cancer: a population-based propensity-score matching study;Journal of Cancer;2023

5. Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer;JTO Clinical and Research Reports;2022-12